Ngokufingqiwe:
• Kuncike ekugxilisweni kwe-vial yakho ethize. Akukho mpendulo eyodwa esebenza kuwo wonke ama-vial.
• Ku-5 mg/mL, i-2.5 mg ilingana nama-unit angama-50. Ku-10 mg/mL, ilingana nama-unit angama-25. Ku-2.5 mg/mL, ilingana nama-unit ayi-100.
• Uma usebenzisa ipeni eligcwaliswe kusengaphambili njenge-Mounjaro noma i-Zepbound, ipeni likuqondela umthamo wakho. Lezi zibalo zisebenza kuphela uma udonsa ku-vial nge-syringe ye-insulin.
I-vial yakho isho ama-milligrams. I-syringe yakho isho ama-units. Futhi azihambisani ngendlela obukulindele ngayo. Sikunikeza ukuguqulwa okuqondile, sikukhombisa izibalo, futhi sichaza ukuthi kungani impendulo ishintsha kuye nge-vial yakho.
Ama-unit ang 2.5 mg ye-Tirzepatide?
Kuncike ekugxilisweni okubhalwe kulokho okuselebula le-vial yakho. Lelo namba likutshela ukuthi mangaki ama-milligrams e-tirzepatide acubusiwe ku-milliliter ngayinye yoketshezi. Amakhemisi ahlukene, ikakhulukazi amakhemisi okuxuba, asebenzisa izinto ezihlukahlukene zokugxilisa.
Nansi eyaziwa kakhulu:
Uma i-vial yakho ithi 10 mg/mL, udonsa ama-unit angama-25. Uma ithi 5 mg/mL, udonsa ama-unit angama-50. Umthamo ofanayo, umthamo owahlukile. Hlola njalo ilebula ku-vial yakho ngaphambi kokudonsa. Ungacabangi ukuthi ihambisana neyokugcina. Hlola i-GLP-1 dose calculator ka-Meet August ukuze uthole imininingwane engcono.
Kungani Inani L Ama-unit Lishintsha Phakathi Kwama-vial?
Ngoba ama-"units" ku-syringe ye-insulin alinganisa umthamo, hhayi amandla omuthi. Amayunithi ayikhulu alingana ne-milliliter eyodwa. Yilokho nje. Ama-units ayindlela nje yokulinganisa ukuthi ungakanani uketshezi odonsayo esigcawini.
Ukugxilisa (mg/mL) kukutshela ukuthi mangaki ama-tirzepatide wangempela afakwe kulokho uketshezi. I-vial egxiliswe kakhulu ifaka imithi eminingi koketshezi oluncane. Ngakho-ke udinga ukudonsa umthamo omncane ukuze uthole umthamo ofanayo we-2.5 mg.
Cabanga ngalokhu. Uma uncibilikisa ithisipuni elilodwa likasawoti engilazini encane yamanzi, isiphuwo ngasinye sinosawoti kakhulu. Uma uncibilikisa lelo thisipuni elifanayo ejageni elikhulu, udinga ukuphuza okuningi ukuze uthole inani elifanayo losawoti. Indaba efanayo ne-tirzepatide.
Ama-vial e-tirzepatide axutshiwe afika ngezindlela zokugxilisa ezihlukahlukene kuye ngokuthi ikhemisi eliwaxuba. Amapeni amabhrendi agcwaliswe kusengaphambili afika ngemithamo ebekiwe futhi awudingi lesi sigaba nhlobo. Lokhu akubhekiseli kumabhrendi noma okuxutshiwe. Kumele nje imithi yoketshezi isebenza kanjani.
Ungaguqula Kanjani i-Tirzepatide mg ku-Units
Udinga izinyathelo ezimbili kuphela. Uma usubone ifomula, iyachazeka.
Isinyathelo 1: Yihlahle umthamo wakho odalelwe ku-mg ngenani lokugxilisa ku-vial yakho ku-mg/mL. Lokhu kukunikeza umthamo ku-mL.
Isinyathelo 2: Phindaphinda leyo nombolo ye-mL ngo-100. Lokhu kukunikeza ama-unit ongawadonsa esigcawini se-insulin.
Nansi isibonelo esisebenza. Ake sithi udokotela wakho uklahlelo u-2.5 mg futhi i-vial yakho ifunda u-10 mg/mL.
- 2.5 ÷ 10 = 0.25 mL
- 0.25 × 100 = 25 units
Esinye isibonelo. Umthamo ofanayo we-2.5 mg, kodwa i-vial yakho ifunda u-5 mg/mL.
- 2.5 ÷ 5 = 0.5 mL
- 0.5 × 100 = 50 units
Uma lokhu kusakuzwakala kunzima, kulungile ngokuphelele. Umhlinzeki wakho odalela umthamo wakho noma usokhemisi angakusiza ngakho nge-vial yakho ethize. Into eyodwa okungafanele uyenze neze ukucabanga.
Udinga Ukuguqula Ama-unit Ngepeni Eligcwaliswe Kusengaphambili?
Cha. Amapeni agcwaliswe kusengaphambili njenge-Mounjaro ne-Zepbound enziwe ukudiliveri imithamo eyiyo ye-milligram. Ukhetha umthamo wakho bese unyova. Akukho syringe, akukho zibalo, akukho ukuguqulwa.
Ngokwezingcaphuno zolwazi lokudayiswa eligunyazwe yi-FDA, ipeni ngalinye eliphumelelayo elinikeza umthamo owodwa lihambisa inani elibekiwe kusuka ku-2.5 mg kuya ku-15 mg ku-0.5 mL wokuxazululwa. Ipeni liyakwenza ukulinganisa kwakho.
Umbuzo wokuguqulwa kwama-unit uvele kuphela lapho udonsa i-tirzepatide ku-vial enomthamo owengeziwe usebenzisa i-syringe ye-insulin. Uma lokhu kungelona isimo sakho, ungakwazi ukukukhipha izibalo nhlobo.
Yini Umthamo Wokuqala W E-Tirzepatide?
Umthamo ojwayelekile wokuqala ngu-2.5 mg, unyovwa kanye ngesonto. Lokhu kusebenza kuMounjaro (okunikezwa isifo sikashukela sohlobo 2) nakuZepbound (okunikezwa ukuphathwa kwesisindo).
Umthamo we-2.5 mg uhloselwe ukuqala kokwelashwa kuphela. Akuyona imthamo yokugcina. Ngemuva kwamaviki amane kuya phambili, udokotela wakho uzokwandisa uye ku-5 mg. Kusukela lapho, imithamo ingakhuphuka ngama-2.5 mg, kungakedluli amasonto amane, kufike ku-15 mg ngesonto.
Isizathu sokwenyuka kancane yizimo ezingase zenzeke. Isicanucanu, isifo sohudo, nokuhlanza yizimpendulo ezivame kakhulu, futhi zivame ukuvela kakhulu phakathi nokushintsha komthamo. Abanye abantu bayaphawula ne-ukugabha okufana ne-sulfur phakathi nokwelashwa nge-tirzepatide, okuyisimo esaziwayo sezinkinga zokugaya esifanele ukuxoxwa nomhlinzeki wakho.
Udokotela wakho unquma ukuthi nini futhi noma uzokwenyusa umthamo wakho ngokuya ngokuthi umzimba wakho usabela kanjani. Akubona bonke abantu abadinga ukufinyelela ku-15 mg. Abanye abantu bayathola imiphumela emihle ngemithamo ephansi.
Ungadonsa Kanjani Futhi Unyove Kanjani i-Tirzepatide Ngokuphepha
Uma usebenzisa i-vial ne-syringe, lezi zinto eziyisisekelo ziyabaluleka.
Hlola njalo izinga lokugxilisa kulebula ye-vial yakho ngaphambi kokudonsa. Njalo njalo. Noma ngabe ucabanga ukuthi uyazi, qinisekisa.
Sebenzisa i-syringe efanele. Izihambisi ze-insulin zilinganisa ngama-units, lapho ama-unit ayikhulu alingana ne-mL eyodwa. Amakhemisi athile athumela izihambisi ezimakiwe ku-mL esikhundleni salokho. Yazi ukuthi uyiphi onayo, ngoba ukudonsa ku-mark engu-25 kusho izinto ezahlukene kakhulu kulowo nalowo.
Ngovo ngaphansi kwesikhumba, okusho ukuthi ngaphansi nje kwesikhumba nangaphakathi komalovu. Izindawo ezintathu ezinconyiwe yisisu, ingaphambili lomlenze wakho, nangemuva lengalo yakho ephezulu. Shintshanisa izindawo masonto onke ukuze indawo efanayo ingadukiwe.
Gcina ama-vial angaqotshiwe esiqandisini phakathi kwamadigri angama-36 kuya kwangama-46 Fahrenheit. Vumela imithi ifike ezingeni lokushisa kwamagumbi ngaphambi kokunqovela. Ukugoba okubandayo kuvame ukubulala kakhulu.
Lahla izinaliti esitsheni sezinto ezibukhali. Hhayi emgqomeni ovamile.
Uma kukhona okungacacile ngale nqubo, thintana nomhlinzeki wakho noma usokhemisi ngaphambi kokunqovela. I-Tirzepatide ingeyomndeni ofanayo wama-agonist e-GLP-1 receptor njengezinye izidakamizwa ezingaveli njengezinye izinto ozaziyo. Uma unentshisekelo yokuthi izidakamizwa ezihlukahlukene kulo mndeni ziqhathaniswa kanjani, lokhu kuhlukaniswa kwe-Trulicity vs. Ozempic kuhlanganisa ezinye zalezo zihlukahluki.
Isiphetho
Ama-unit angama-2.5 mg we-tirzepatide kuncike ekugxilisweni kwe-vial yakho. Ku-5 mg/mL angama-50 units. Ku-10 mg/mL angama-25 units. Ku-2.5 mg/mL angama-100 units. Uma usebenzisa ipeni eligcwaliswe kusengaphambili, ipeni liyakwenzela lona.
Ifomula ilula. Yihlahle umthamo wakho we-mg ngenani lokugxilisa, bese uphindaphinda ngo-100. Kodwa uma kukhona ukungabaza nhlobo, shayela usokhemisi wakho noma umhlinzeki wakho ngaphambi kokudonsa. Ukuthola umthamo olungile kuyisinyathelo esisodwa ongakwazi ukubeka engozini.
Imibuzo Evame Ukubuzwa
Kwenzeka ngani uma ngidonsa inani elingalungile lama-unit omthamo wami ongu-2.5 mg?
Kuncike ukuthi ungakanani lapho ungcolile khona. Uma udonsa kancane kunokudingekayo, uthola umthamo ophansi kancane, okungavamile ukuba yingozi kodwa kunganciphisa ukusebenza komuthi ngalolo hlangothi.
Uma udonsa kakhulu kunalokho okubhalelwe, ukwandisa ingozi yezimo ezingase zenzeke njengokucanucanu okunzima, ukuhlanza, isifo sohudo, ukoma, futhi ezimweni ezingavamile i-pancreatitis. Ungazami ukulungisa iphutha lomthamo ngokudonsa omunye umjovo ukuze ulungise umehluko. Shayela udokotela wakho odalela umthamo wakho noma usokhemisi esikhundleni salokho. Bangakutshela ukuthi ungaphuthelwa yini umthamo wakho olandelayo, ulinde, noma uthathe isinyathelo sokulungisa. Uma ungabaza, hlola njalo nabo ngaphambi kokunqovela.
Ngingasebenzisa i-syringe evamile esikhundleni se-syringe ye-insulin ye-tirzepatide?
Ngokobuchwepheshe yebo, Izihambisi ze-insulin zimakwe ngokukhethekile ngama-unit (lapho ama-unit ayikhulu alingana ne-mL eyodwa), okwenza ukuguqulwa kusuka ekugxilisweni kwe-vial yakho kube lula. Izihambisi ezijwayelekile zimakwe ku-mL kuphela, ngakho-ke kufanele uguqule impendulo yakho yama-unit ibuyele ku-mL.
Uma i-vial yakho ingama-10 mg/mL nomthamo wakho ungu-2.5 mg, lokho kungama-0.25 mL kusihambisi esijwayelekile. Uma ikhemisi likuthumele isihambisi esijwayelekile esikhundleni se-syringe ye-insulin, libizele ubuyele kuleso esifanele. Ungakuhlohloli ngamehlo. Imithamo incane ngokwanele kangangokuthi ngisho nokulinganisa okuncane ngokubukeka kungaphazamisa umthamo wakho.
Kungani izinga lokugxilisa le-vial yami lihlala lishintsha phakathi kokugcwaliswa kwekhaya lekhemisi?
Lokhu kwenzeka kakhulu nge-tirzepatide exutshiwe ngoba amakhemisi okuxuba ahlanganisa imithi ngezindlela zokugxilisa ezihlukahlukene kuye ngokutholakala kwawo, ukwakhiwa, kanye nesidingo somguli. Amapeni amabhrendi akwaMounjaro ne-Zepbound agcwaliswe kusengaphambili awashintshi izinga lokugxilisa. Kodwa uma uthola i-tirzepatide exutshiwe kumavial, i-batch yakho elandelayo ingaba ngu-5 mg/mL lapho i-batch yakho yokugcina yayingu-10 mg/mL.
ngakho-ke kungani kufanele uhlole ilebula njalo njalo. Uma izinga lokugxilisa lishintsha ngaphandle kwesaziso, lokho akusona isithiyo, kodwa buza usokhemisi wakho ukuthi kungani lishintshile. Amakhemisi athile athumela imiyalezo yombhalo mayelana nokushintsha kwezinga lokugxilisa, kanti amanye awenzi.
Ngiwazi kanjani ukuthi ngiyidonsa kahle i-tirzepatide esigcawini se-insulin?
Bamba isihambisi ukuze i-needle ibheke phezulu bese uhlola ukuthi izinga loketshezi lihambisana ncamashi ne-mark yama-unit oyibale. Buka isihambisi ngezinga leso, hhayi kusuka ngaphezulu noma ngaphansi, ngoba i-parallax ingaqamba phansi lokho okubonayo. Bamba isihambisi kancane ukuze uthumele noma yimaphi amagwebu omoya phezulu, bese ucindezela i-plunger kancane ukuze uwakhiphe. Amagwebu athatha umthamo okufanele kube imithi, ngakho amagwebu asho ukuthi unyova kancane kunokuhloselwe. Uma umusha ekwenyoveni, cela usokhemisi wakho akuhambise ngobhukuphuku esikhathini esisodwa mathupha. Amakhemisi amaningi enza lokhu mahhala.
Kuthiwani uma ngiphuthelwa umthamo wami wamasonto onke we-tirzepatide?
Kuncike ukuthi sekudlule isikhathi esingakanani. Uma kungaphansi kwezinsuku ezine kusukela kumthamo wakho ohleliwe, uwudle ngokushesha lapho uwukhumbula, bese uqhubeka neshejuli yakho yamasonto onke. Uma sekudlule izinsuku ezine, phuthelwa umthamo owuphuthelwe bese nje uthatha umthamo wakho olandelayo ngesikhathi sakho esivamile.
Ungadluli ukuze ulungise, ngoba lokhu kukwandisa ingozi yezimo ezingase zenzeke. Uma uphuthelwa imithamo njalo, khuluma nodokotela wakho mayelana nokulungisa usuku lwakho lokugoba ukuze luhambisane neshejuli yakho. Ukungaguquguquki kubaluleke kakhulu nge-tirzepatide kunangezinye izidakamizwa zamasonto onke.
